Mylan pays $130M for basket of Aspen Pharmacare drugs
Industry steps up interest in developing countries
AZ’s Fasenra offers severe asthma patients 2 years of benefits
How big pharma both repels and embraces innovation
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
